Moderna To Apply For FDA Authorization For Its Covid-19 Vaccine

  • 30/11/2020

Washington : On Monday, biotechnology company Moderna announced that it plans to request an Emergency Use Authorization from the US Food and Drug Administration and conditional approval from the European Medicines Agency for its coronavirus vaccine. In a statement, the company said that the vaccine efficacy against Covid-19 was 94.1 percent and that efficacy against severe Covid-19 was 100 percent. It also affirmed "A continuous review of safety data is ongoing and no new serious safety concerns have been identified by the company," Stephane Bancel, Chief Executive Officer of Moderna said that "We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death,"

Related News